Telmisartan is an antihypertensive drug that inhibits angiotensin II
receptors type AT1. Studies showed drug interactions with different
potentials. This study was intended to investigate the role of some
active ingredients acting on influx, efflu
x and metabolizing
enzymes in intestinal absorption of telmisartan prior to hepatic-pass
effect. Intestinal perfusion with venous sampling technique was
applied in rats by perfusing telmisartan in intestinal lumen, and
measuring its concentration and amount versus time.
This paper presents a new solution that allows the doctors to know drug interactions,
considering other affecting factors such as the patient's age, weight, physiological and
pathological condition. This solution is characterized by being increment
al, not only by
enriching the database with drug interactions information, but also by its ability to conclude
other interactions through a built-in expert system. The system concludes drugs interactions
based on its active substrates and the potential interactions between them or between the drugs
families. The system serves in three ways; it determines whether the patient illness is possibly
due to the medications he is on. It alerts the doctor to the interaction of the newly prescribed
medication with the patient’s medications, and to its influence on the patient’s physiological or
pathological condition. Besides, it suggests alternative drugs when needed. The solution offers
additional services such as binding between the brand name and the generic drug, and between
drugs and diseases.
النظم الخبيرة
التداخلات الدوائية
الحالة الفيزيولوجية
الحالة المرضية
الآثار الجانبية
العائلة الدوائية
المادة الفعالة
الاسم العلمي
الاسم التجاري
الاستطبابات
Expert Systems
Drugs Interactions
Active Substrate
Medical Group
Genuine Name
Trade Name
physiological condition
pathological condition
Side Effects
Indications
المزيد..